Back to Trades
Patience David
Chief Financial OfficerCIK 0001970009
Profile
- Filings
- 5
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Patience David, Chief Financial Officer, has filed 5 SEC reports (2025–2026), all concentrated in TriSalus Life Sciences, Inc. (TLSI), totaling $3.2M in disclosed volume. Weighing $17.3K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $17.3K in TriSalus Life Sciences, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jul 6 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Tax withheld | $65.3K |
| May 18 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Buy | $17.3K |
| Nov 25 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Grant | $721.5K |
| Aug 29 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Award | $1.3M |
| Aug 15 | TLSI TriSalus Life Sciences, Inc. | Patience David | Chief Financial Officer | Grant | $1.1M |
5 filings